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Objectives: The aim of this study was to analyze the effects of treatment by hydrotherapy 
on quality of life, perception of pain and the severity of depression in a group of patients 
with fi bromyalgia. 
Materials and methods: We evaluated 64 females divided into two groups: hydrocinesiother-
apy (n = 33, 58.2 ± 10.6 years) and control group (n = 31 with 59.6 ± 9.4 years) with clinical 
diagnosis of fi bromyalgia. Individuals were assessed by Visual Analog Scale of Pain (VAS), 
the Fibromyalgia Impact Questionnaire (FIQ) and the Beck Depression Inventory. Partici-
pants underwent a treatment in a hydrotherapy pool heated to 33°C over a period of 15 
weeks, two sessions per week of 45 minutes, a total of 30 sessions. The exercises were 
underwater: cardiovascular conditioning, strength training, mobility, coordination, balance 
and still, stretching exercises and muscle relaxation. The ANOVA 2×2 and Kruskall-Wallis 
was used for statistical analysis Results: There were statistically signifi cant improvements 
in the perception of pain intensity (Δ% = -28.2%, p < 0, 01), quality of life (Δ% = -32.4%, p < 
0, 05) and depression symptoms (Δ% = -35.4%, p < 0, 05) in favor of the Hydrotherapy group 
compared to the control group. 
Conclusions: The study suggests that hydrocinesiotherapy was effective as an alternative 
therapy for fi bromyalgia, however further studies are recommended to test the associa-
tions between the variables and intervention programs and using the water activities, and 
the modifi ability of the parameters of physical and mental health when these individuals 
undergo programs of short, medium and long duration.
© 2013 Elsevier Editora Ltda. All rights reserved.
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Dor, qualidade de vida, autopercepção de saúde e depressão de 
pacientes com fi bromialgia, tratados com hidrocinesioterapia
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r e s u m o
Objetivos: Analisar os efeitos do tratamento hidrocinesioterapêutico na qualidade de 
vida, percepção de dor e gravidade de episódios depressivos em um grupo de pacientes 
com fi bromialgia. 
Materiais e métodos: Foram avaliados 64 indivíduos do sexo feminino, separados em dois 
grupos: hidrocinesioterapia (n = 33; 58,2 ± 10,6 anos) e grupo controle (n = 31; 59,6 ± 9,4 
anos), com diagnóstico de fi bromialgia. Os indivíduos foram avaliados através da Escala 
Analógica Visual de Dor (EVA), o Fibromyalgia Impact Questionnaire (FIQ), e o Inventá-
rio de Beck. Os participantes foram submetidos a um tratamento hidrocinesioterápico 
numa piscina aquecida a 33°C com duas sessões de 45 minutos por semana, ao longo 
15 semanas, num total de 30 sessões. Os exercícios subaquáticos foram: de condiciona-
mento cardiovascular, de força, de mobilidade, de coordenação, de equilíbrio, de alon-
gamento e de relaxamento muscular. Utilizou-se a ANOVA 2×2 e Kruskal-Wallis para 
análise estatística. 
Resultados: Foram observadas melhorias estatisticamente signifi cativas na percepção da 
intensidade da dor (Δ% = -28,2%, p < 0,01), na qualidade de vida (Δ% = -32,4%, p < 0,05) e 
nos sintomas de depressão (Δ% = -35,4%, p < 0,05) favoráveis ao grupo hidrocinesiotera-
pia comparado ao grupo controle. 
Conclusões: O estudo sugere que a hidrocinesioterapia mostrou-se efi caz como terapia al-
ternativa da fi bromialgia. No entanto, recomenda novos estudos que testem as associações 
existentes entre as variáveis analisadas e os programas de intervenção, utilizando as ativi-
dades aquáticas, bem como a modifi cabilidade dos parâmetros de saúde física e psíquica 
quando estes indivíduos são submetidos a programas de curta, média e longa duração.
© 2013 Elsevier Editora Ltda. Todos os direitos reservados.
Introduction
Fibromyalgia (FM) is a rheumatic condition of little known 
etiology, characterized by chronic generalized pain and re-
duced pain threshold, with hyperalgesia and allodynia,1 
featuring some associated symptoms such as fatigue, sleep 
disorders,2 impaired physical capacity and ability,3,4,5 espe-
cially functional capacity,6,7 and reduced muscle strength.8, 
9,10 Moreover, there are peculiar psychological characteris-
tics, such as high levels of anxiety, depression, and perceived 
stress.11,12 
The prevalence of FM in the Brazilian population ranges 
from 2.5% to 4.4%.13 Individuals diagnosed with the disease 
require permanent analgesic therapies, and their demand 
for medical services is higher when compared with that of 
the general population.14 
The percentage of depressive symptoms is high in this 
population, ranging from 40% to 80%,5,15 with an approxi-
mately fi ve-fold higher chance of experiencing depression 
when compared to healthy subjects.16 Thus, depression may 
trigger or worsen the symptoms of this disease.5, 17,18  
The complex symptomatology of FM involves three main 
areas: physical aspects of health (musculoskeletal system), 
pain regulatory mechanisms (neuroendocrine), and fac-
tors related to the individual’s psychological well-being and 
mental health.19,20 The most appropriate approach in the 
context of physical health is therapy aimed to assist the 
more usual types of therapies and interventions,14, 21,22 since 
FM is a chronic condition that triggers musculoskeletal pain 
and many other symptoms. 
The treatment of FM is usually based on pharmacological 
techniques23 in order to relieve pain, minimize depression, 
and improve quality of life.24 However, this treatment has 
limitations and can result in unwanted side effects.25,26,27 The 
modest effect of pharmacotherapy performed in isolation has 
led to the inclusion of other factors required for treatment. 
In this sense, the practice of physical exercises has shown 
promising results for this population.28 Among the interven-
tions with physical exercises, hydrokinesiotherapy stands out 
for the treatment and prevention of musculoskeletal pain, 
and has shown benefi cial results for patients with chronic 
pain,29 specifi cally those with FM.30 
Water therapy performed in heated water is recommend-
ed as a treatment for patients with FM due to the benefi ts 
provided by the environment,31 as the water allows for body 
immersion and fl oating, facilitates the reproduction of com-
pound movements safely and in several forms, and mini-
mizes the impact (when compared to fl oor exercises), which 
can allow for body mobility and fl exibility work in a safe and 
gradual manner.32 Furthermore, individuals with FM report a 
sense of “global relaxation” caused by the water, combined 
with a “sense of relief” of symptoms after the intervention.33
According to Valim,34 there have been few studies in the 
scientifi c literature using hydrokinesiotherapy in FM patients. 
However, the difference in these types of intervention is in the 
planning of a therapeutic program that involves, among other 
variables, the type of treatment and the effective control of 
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the duration, volume, and intensity of exercises, according to 
the guidelines for exercise prescription by the American Col-
lege of Sports Medicine (ACSM).35 
Therefore, this study aimed to analyze the effects of hy-
drokinesiotherapy treatment on pain perception, quality of 
life, and depressive symptoms in female individuals with a 
diagnosis of FM. 
Material and methods
The present experimental study was conducted at the Clíni-
ca-Escola de Fisioterapia Maria de Almeida Santos of the Cen-
tro Universitário da Fundação Educacional Guaxupé (Unifeg), 
Guaxupé, Minas Gerais, Brazil, from December of 2010 to April 
of 2011. 
The project was approved by the Research Ethics Com-
mittee of Unifeg (133/2010), and met the standards for the 
Research in Humans of the National Health Council, Resolu-
tion 196/96 of 1996 and the Declaration of Helsinki.36 All par-
ticipants were informed about the objectives of the study and 
signed an informed consent before the intervention proce-
dures were conducted. 
Participants
The study was widely publicized by the local media, in or-
der to receive the highest number of volunteers. Therefore, it 
was possible to select participants with FM referred by physi-
cians of different specialties. Thus, 64 women with a clinical 
diagnosis of FM confi rmed by clinical rheumatologists from 
the Clínica-Escola de Fisioterapia Maria de Almeida Santos of 
the Unifeg according to the criteria of the American College of 
Rheumatology were selected to participate in the study.37 The 
volunteers were randomly separated, by drawing lots, into 
two groups: the hydrokinesiotherapy group (n = 33 partici-
pants aged 58.2 ± 10.6 years), and the control group without 
exercise (n = 31 participants aged 59.6 ± 9.4 years). 
Throughout the study, the participants used only muscle 
relaxant drugs and painkillers prescribed and monitored by 
their physicians. The hydrokinesiotherapy group participants 
were instructed to perform only the activities proposed by the 
study, whereas the control group did not have any other di-
rected physical therapy during the study. None of the patients 
had undergone physical therapy within six months prior to 
the study. Inclusion criteria were female gender, age 50 years 
or older, and FM diagnosis confi rmed by a rheumatologist.  
The following exclusion criteria were used: uncontrolled 
hypertension, wounds, any type of infectious disease, and/or 
disabling chronic clinical picture or associated chronic pain. 
According to these criteria, two volunteers were excluded, as 
they met some of the above criteria and because they did not 
have FM diagnosis. None of the participants were undergo-
ing any other type of physical treatment and remained so 
throughout the study. At the end of the study, the hydroki-
nesiotherapy group had a total of 33 participants, aged 58.2 
± 10.6 years; two volunteers from the control group did not 
attend the fi nal evaluation, and thus this group had a fi nal 
sample of 31 participants aged 59.6 ± 9.4 years. The entire pro-
cess of sample selection is shown in Fig. 1.
Procedures
After the initial medical procedures, the following evaluations 
were performed: anthropometric measurements, quality of 
life, depressive symptoms, and pain scale. The participants 
underwent an evaluation before and after the hydrokinesio-
therapy intervention. 
Anthropometric assessment
Body mass was obtained using a platform scale with a 150 kg 
capacity and 50 g graduation manufactured by Kratos® (Embu, 
Brazil). Height was measured using the stadiometer attached 
to the same scale, to the nearest 0.1 cm. The body mass index 
(BMI) value was obtained in accordance with the Anthropo-
metric Standardization Reference Manual.38 
Pain intensity assessment 
Pain intensity assessment was performed using the visual an-
alog scale (VAS) for pain. This scale ranges from 0 to 10 cm, in 
which 0 represents no pain or discomfort, and 10 represents 
the worst possible pain experienced by the patient.39 
Quality of life assessment 
The tool used to assess the impact of FM on quality of life 
was the Fibromyalgia Impact Questionnaire (FIQ). This 
questionnaire takes into account the dimensions of an in-
dividual’s life that may be affected by the syndrome, i.e., 
the physical dimension associated with the functional ca-
pacity, state of mental health, and feelings of well-being 
or pain. This tool has shown to be easy to understand and 
apply. It consists of 19 questions; the higher the fi nal score, 
the greater the impact of FM on quality of life. The ver-
sion used for this study was translated and validated by 
Marques et al.40
Evaluation of depressive symptoms
Beck’s Depression Inventory was applied to assess depressive 
symptoms. This tool consists of 21 items, where each ques-
Excluded (n = 2)
Refused to 
participate (n = 0)
(n = 66)
(n = 33)
Control group 
(n = 33)
Intervention
withdrawn 
(n = 2)
Analyzed group
(n = 31)
(n = 0)
Analyzed group
(n = 33)
(n = 68)
Evaluation for
Eligibility
Random
process
Hydrokinesiotherapy
group 
Intervention
withdrawn 
Fig. 1 – Sample selection process.
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tion has four answer options with varying degrees of intensity 
from 0 to 3, and the sum of scores ranges 0 zero to 63.41 Ac-
cording to the original authors, this tool has a  high reliability 
(0.86) when their results were compared with diagnoses by 
other professionals. The version translated into Portuguese by 
Goreinstein and Andrade was used in this study.42
Characterization of hydrokinesiotherapy treatment
The intervention treatment with hydrokinesiotherapy was 
performed in a pool heated to 33º C, with a depth of 1.30 m.
The participants underwent 30 treatment sessions of 45 
minutes each, twice a week, totaling 15 weeks of interven-
tion. All sessions consisted of exercises in the water, divided 
into three parts and performed as follows: 1) fi ve minutes of 
warm-up exercises and preparatory movements, 2) 35 min-
utes of exercises aimed to develop strength, mobility, balance, 
coordination, and agility, through the use of small aquatic 
equipment in order to increase exercise intensity (e.g. dumb-
bells, mini-arches, exercise balls, pool noodles); 3) Finally, fi ve 
minutes of stretching and relaxation. Exercise intensity was 
measured constantly through an adapted subjective scale of 
exertion (PSE) developed by Cavassini and Matsuda.43 The PSE 
was determined by an arbitrary scale 0 zero to 10, with identi-
cal intervals and reference to the quality of effort performed, 
i.e. (0-2) very light, (3-5) light, (6-7) moderate, (8-9) intense, and 
(10) very intense.
The objective was to control the exercise at a PSE of 6 
and 7, because it was expected that the real exertion would 
be between 60% and 70% of the maximum heart rate, val-
ues  recommended by the ACSM as adequate work inten-
sity for individuals with FM undergoing exercise therapy, 
as demonstrated by some studies. 34,35,44 The participants in 
the control group were instructed to refrain from perform-
ing any type of intervention or physical therapy during the 
study period. 
Statistical analysis 
Statistical analysis was performed using PASW®, release 17.0 
for Windows, with a P-value (α) < 0.05. Initially, a descriptive 
analysis was performed with mean and standard deviation 
values of the pre-test data from the study group variables. 
Subsequently, the Shapiro-Wilk normality test was per-
formed. The ANOVA (2x2) test was used when there was nor-
mality; Levene’s test confi rmed the homogeneity of variance, 
and the Kruskal-Wallis test was used for nonparametric data. 
Finally, to calculate the difference in percentage, the formula 
Δ% = [(Post-test - test) * 100/Test] was used.
Results
Table 1 shows the descriptive statistics of both groups for all 
variables studied. There  are no signifi cant differences be-
tween the groups regarding the entry data for all variables, 
showing that the two groups had similar characteristics be-
fore the intervention.
The analysis results of the two moments of assessment for 
pain intensity, performed by intra- and intergroup compari-
son using the VAS protocol, demonstrated that after the inter-
vention period there was a statistically signifi cant improve-
ment (P < 0.05) in the intra-group analysis for the following 
variables: cervical, trochanter, and total VAS. Moreover, there 
was a statistically signifi cant difference (P < 0.05) in favor 
of the hydrokinesiotherapy group regarding the inter-group 
analysis for the following variables: occipital (Δ% = -24.7%, P = 
0.001), cervical (Δ% = -38.8%, P = 0.003), trapezius (Δ% = -13%, 
P = 0.005), supraspinatus (Δ% = -20.1%, P = 0.01), gluteus (Δ% = 
-31.6%, P < 0.001), trochanter (Δ% = -46.8%, P < 0.001), and for 
the total score of the VAS protocol (Δ% = -28.2%, P <0.001), as 
shown in Fig. 2. 
Fig. 3 shows the data on the impact of FM on quality of life, 
demonstrating that there was a statistically signifi cant differ-
ence in both intra- and intergroup analysis (Δ% = -32.4%, F = 
37.7, P <  0.001) .
Fig. 4 shows the results of the participants’ depressive 
symptoms. Statistically signifi cant intra- and intergroup dif-
ferences (P < 0.05) were also observed for this variable, favor-
able to the hydrotherapy group (Δ% = -35.4%, F = 27.4, P <0.001) 
when compared with the control group. 
Table 1 – Descriptive analysis of data from study groups.
Hydrotherapy; 
n = 33
Control group; 
n = 31
Variables Mean SD Mean SD P-value
Age (years) 58.2 10.6 59.6 9.4 0.579
Mass (kg) 71.9 10.2 69.8 6.9 0.336
Height (cm) 159.8 4.6 161.2 5.4 0.251
BMI (kg/m2) 28.3 4.6 29.9 3.4 0.202
Beck (score) 25.6 5.6 24.06 5.1 0.258
Total VAS 
(score)
60.1 5.7 59.8 5.6 0.824
FIQ (score) 78.5 11.1 75.7 10.3 0.306
SD, standard Deviation; BMI, body mass index; VAS, visual analog 
scale for pain; FIQ, Fibromyalgia Impact Questionnaire. 
Fig. 2 – Analysis of pain using the visual analog scale (VAS) 
protocol. * P < 0.05 for the intergroup comparison. # P < 0.05 
for the intragroup comparison. 
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Discussion
FM constitutes a severe health problem that has socioeconom-
ic implications, with a negative individual, familial, and social 
impact.45 Thus, programs and alternative therapies of proven 
effectiveness in alleviating its symptoms may represent an in-
tegrated low-cost solution for its treatment.46 Studies using the 
FIQ that included in their experimental design an intervention 
model comprising physical exercise outside the aquatic envi-
ronment are more frequent in the current literature.47 
Perhaps due to the high cost related to the maintenance 
and treatment of the pool, models that used activities in the 
water combined with exercise therapies outside of the water 
are also more frequent.48 The objectives of these trials, con-
trolled by two types of activities, aim to test the evidence that 
the water is able to induce a state of relaxation along with the 
perception of pain symptom relief reported by the patients.
The present study corroborates the literature,32 as it ob-
served a positive effect on the results of pain symptom inten-
sity assessment performed through the VAS, which indicated 
a decreased perception of pain, with statistically signifi cant 
differences. Bastos and Oliveira stated32 that therapies in wa-
ter are benefi cial for patients with FM, as the movements in 
the water are slower due to its physical properties, thereby 
promoting overall muscle relaxation.
In this study, in addition to improvement in the percep-
tion of pain symptoms, there was a lower impact of FM on 
quality of life of those participating in the hydrokinesiother-
apy group. Similarly, Tomas-Carus et al. (2007)49 also reported 
improvement in the physical and psychological dimensions 
(FIQ) in a 12-week controlled clinical trial, whose protocol was 
performed three times a week and used the aquatic environ-
ment as a therapeutic resource. 
Individuals with FM are usually affected by depressive 
symptoms.5  In this study, high values in the Beck Depression 
Inventory were observed in both groups before the interven-
tion (Table 1), which demonstrated elevated depressive symp-
toms in these patients. The hydrokinesiotherapy program 
of the present study was effective in decreasing depressive 
symptoms when compared to the control group (Fig. 4), which 
is in agreement with recent studies that used treatment pro-
grams with similar time and duration.50 The same was ob-
served in the study performed by Jorge et al.,51 in which the 
authors emphasize the importance of continuity of care, since 
the results were not favorable after six months and there was 
no intervention program. 
Considering that the objective of this study was to veri-
fy the effects of hydrokinesiotherapy on perception of pain, 
quality of life, and depressive symptoms in women diagnosed 
with FM, it is noteworthy that the proposed treatment was 
shown to be benefi cial for all evaluated dimensions.
Control of factors such as treatment time, duration, fre-
quency, and type of activities can be crucial for positive re-
sults in intervention studies.52 It should be emphasized that 
all the participants of the present study successfully adhered 
to the program regarding the frequency, with no record of 
therapy interruption in the group that performed the hydro-
kinesiotherapy.
However, studies have demonstrated that interrupting 
the treatment also causes signifi cant loss of results, and thus 
most programs should be continued and have a diversity of 
activities; the inclusion of other practices or physical activi-
ties are recommended in the program in order to motivate the 
participants and reduce intervention interruptions.51
 Regarding the modifi ability of the psychological state 
evaluations in this type of treatment, the literature states that 
medium and long-term studies whose interventions last be-
tween 12 and 24 weeks promote a positive change and have 
a longer-lasting effect.33,53 An interesting fact is that the mere 
encouragement through a dialogue aimed to explain in de-
tails the importance of looking for alternative treatments for 
FM was effective for the enrollment of these individuals into 
an integrated treatment program, such as physical exercise-
directed therapy. 54
Fig. 3 – Fibromyalgia Impact Questionnaire (FIQ) protocol 
analysis. * P < 0.05 for the intergroup comparison. # P < 
0.05 for the intragroup comparison. 
Fig. 4 – Beck protocol analysis. * P < 0.05 for the intergroup 
comparison. # P < 0.05 for the intragroup comparison. 
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The authors of this study54 also reported signifi cant im-
provement in self-effi cacy for exercise, psychological symp-
toms, and quality of life of patients; however, they make it 
clear that the motivational intervention strategy was decisive 
for treatment success. In fact, patients with FM signifi cantly 
associate physical performance, quality of life, and cognitive 
performance, because these dimensions are shown as strong 
indicators of quality of life.55 
Regarding drug treatment, there was no effective control 
for this variable by researchers; this can be an important 
study limitation, because the type and amount of adminis-
tered medications may affect the results. According to Assis 
et al.56 FM treatment using exercises in the water associated 
with drug treatment can bring benefi cial effects, particularly 
regarding the psychological aspects. In the same study, the 
authors reported that throughout the intervention process an 
analgesic dose of only up to 3 mg/day was allowed. Therefore, 
further studies to evaluate this effect associated with hydro-
kinesiotherapy are recommended.
Conclusion
The study suggests that the hydrokinesiotherapy is effective 
as an alternative therapy in the treatment of FM. A statisti-
cally signifi cant improvement was observed in all evaluated 
dimensions, including aspects related to physical health and 
also to the individual perceptions of the psychological state 
related to FM. Many authors state that the modifi ability of 
these dimensions during treatments that use non-drug ap-
proaches is essential in order to encourage individuals to 
maintain continuous and uninterrupted therapy. 
Regarding methods that include practice of exercises in 
water, control of variables such as volume, intensity, and du-
ration of intervention time are crucial, as they can provide 
information about the quantity and quality of intervention 
time required to promote positive changes in the perceptions 
of individuals with FM and the duration of their effects.  
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